https://www.selleckchem.com/pr....oducts/talabostat.ht
To provide real-world data on the world-wide-web for patient and doctor awareness. From December 2017 to January 2020, consecutive patients with choroidal melanoma (CM), iris ciliary body melanoma (ICM), and ocular surface squamous carcinoma (OSSC) had specific outcomes recorded at each return visit. Each result was anonymized, entered in an online portal, and sent to a unique software program where it was used to create real-world data of number of patients, mean vision, local tumor control, eye salvage, systemic metastases, and len
Curtir
Comentario
Compartilhar
